Guides for patients and providers in English, Spanish, and Chinese. STOMP (www.stomptpoxx.org) is a clinical trial of oral tecovirimat (TPOXX) safety and efficacy. It is the preferred strategy for clinicians and local health jurisdictions to access oral TPOXX.
For Providers:
For Patients:
For Providers:
For Patients:
For Provider:
For Patients:
For Providers:
For Patients
What, how, and why to talk to your clients about Doxy-PEP.
Wed, May 10, 2023 12:00 PM – 1:45 PM PDT
This webinar is offered by th
According to the National Survey of Family Growth, approximately 12% of “women of childbearing age” have a disability, and yet our educational and training programs devote little to no time in preparing us to provide accessible, appropriate, quality services to these populations. This webinar will define the population, identify the sexual and reproductive health needs, barriers to health care and health care disparities for people with disabilities, and present best practices for providing accessible, equitable sexual and reproductive health care for people with disabilities. This webinar will also discuss actionable items providers can immediately implement in their practices to make them disability accessible.
Learning Objectives
Presenters:
Erica Monasterio, MN, FNP-BC-Retired
Robin Wilson-Beattie, BA
What are appropriate treatment intervals for late latent syphilis or syphilis of unknown duration in non-pregnant people?
Prepared by the STD Control Branch, California Department of Public Health and California Prevention Training Center. Revised February 2023.
Tuesday, March 28, 2023 from 12:00-1:15PM (PDT)
A review of screening, treatment, and vaccination tools to prevent STIs and HIV.
Presented by Drs. Caterina Liu and Kurtis Mohr
Learning Objectives:
December 16, 2022
Description
This webinar is presented by Gayge Maggio, FNP-BC, AAHIVS and will focus on the reproductive and sexual health needs/considerations of transgender and gender non-conforming people. There will be a focus on learning to approach sexual health in a culturally sensitive, non-judgmental manner and how to deliver family planning needs and contraceptive options for patients who identified as transgender and/or non-binary.
Objectives
Speaker:
Gayge Maggio (She/They) FNP-BC, AAHIVS
Nurse practitioner working at Callen-Lorde Community Health Center in New York City, an LGBTQ+ focused federally qualified health center FQHC
She works as a primary care provider, providing primary care including sexual and reproductive health services, gender-affirming hormone therapy (GAHT), treatment of HIV, and substance use disorder (SUD) treatment
She also works in the FlexCare program, providing walk-in primary care to patients
Resources:
October 19, 2022
Description
Quality contraceptive care is more than just knowing the facts about all available birth control methods. In order for clients to select methods and get what they want from their birth control, it is crucial to provide contraceptive counseling that helps people identify their preferences in the context of their lives, values, and beliefs. This webinar will review best practices in person-centered contraceptive counseling and offer practical tools for providers to employ in their clinical encounters.
Objectives
Speakers:
Nurse Practitioner at Vista Community Clinic
National Trainer for Envision SRH & the PATH Framework Sexual and Reproductive Health Trainer and Consultant
Contributing author for the upcoming 22nd Edition of Contraceptive Technology
Assistant Clinical Professor
UCLA School of Nursing
President, Envision SRH
Resources:
August 17, 2022
Description:
Since the first HPV vaccines were introduced in 2006, rates of cervical cancer and other HPV-related cancers have decreased in immunized populations. Family PACT will add HPV immunization as a benefit in July 2022 and will utilize guidelines developed by the CDC Advisory Committee of Immunization Practices (ACIP). This webinar will provide information about the effectiveness and safety of the HPV vaccine, review the current CDC recommendations for the use of the 9-valent HPV vaccine, and provide advice on how to have effective shared decision-making conversations with clients about being immunized. In addition, new Family PACT policies about coding and billing for HPV immunization services will be discussed. There will be ample time for your questions at the end of the presentation.
Learning Objectives:
• List 2 effective strategies for engaging with patients who have vaccine hesitancy
• Demonstrate a person-centered technique for providing a strong recommendation without coercion
• Describe the impact of HPV vaccination on the natural history of HPV
• Discuss the safety profile of HPV vaccines
Speakers:
Assistant Clinical Professor
UCLA School of Nursing
President, Envision SRH
Professor Emeritus, UCSF
Senior Medical Advisor, CAPTC and California OFP
Clinical Fellow, NFPRHA
Resources:
Transcript: Talking with Family PACT Clients About HPV Immunization
Slide deck: Talking with Family PACT Clients About HPV Immunization
Q and A: Talking with Family PACT Clients About HPV Immunization
The long-awaited 2021 CDC Sexually Transmitted Infections Treatment Guidelines were published in MMWR on July 22, 2021. This webinar will focus on significant changes from the 2015 CDC STD Treatment Guidelines, including updated guidelines for the screening, diagnosis and treatment of gonorrhea, chlamydia, syphilis, pelvic inflammatory disease, genital herpes, Mycoplasma genitalium, and vaginal trichomoniasis. To assist health care providers in obtaining a sexual history, the updated “Five P’s” approach will be reviewed. In addition, current Family PACT benefits for each type of sexually transmitted infection discussed in the program will be explained.
Learning Objectives:
Presenters:
Resources:
August 26, 2021
This webinar is presented by Gayge Maggio, FNP-BC, AAHIVS and will focus on the sexual health needs of transgender and gender non-conforming people.
There will be a focus on learning to approach sexual health in a culturally sensitive, non-judgmental manner.
Unique PrEP and PEP considerations in TGNC populations will be covered, as will contraceptive options for female assigned at birth TGNC patients.
Learning Objectives: